Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 8.04% of ...

Piper Sandler analyst Jason Bednar maintained a Buy rating on Masimo (MASI – Research Report) today and set a price target of $165.00.

Notable insider trades include REYNOLDS CRAIG B, Director at Masimo Corp (MASI), who sold 40000 shares on Apr 26 ’24, at $136.17 each, totaling $5.45 million.

MASI is a #2 (Buy) on the Zacks Rank, with a VGM Score of A. Momentum investors should take note of this Medical stock. MASI has a Momentum Style Score of A, and shares are up 25.2% over the past ...

Technical analysis for Masimo Corporation MASI including support levels resistance levels and stop losses for MASI ...

Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointments of Timothy J. Scannell and Wendy E. Lane to the Company's Board of Directors (the "Board"), ...

For Masi, 37, there’s nothing finer in life than beholding a beautiful cathedral or basilica and that’s why he began a ...

Masimo (MASI) shares soared 8.7% in the last trading session to close at $121.42. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to ...

Northwestern Mutual Wealth Management Co. grew its position in Masimo Co. (NASDAQ:MASI – Free Report) by 133.3% during the ...

Bird & Bird, an international law firm, has announced the appointments of disputes partner Bill Smith and restructuring ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.